Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Venlafaxine-associated mania.

Shulman RB, Scheftner WA, Nayudu S.

J Clin Psychopharmacol. 2001 Apr;21(2):239-41. No abstract available.

PMID:
11270924
2.

Possible venlafaxine-induced mania.

Stoner SC, Williams RJ, Worrel J, Ramlatchman L.

J Clin Psychopharmacol. 1999 Apr;19(2):184-5. No abstract available.

PMID:
10211922
3.

Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.

Ashton AK, Longdon MC.

Am J Psychiatry. 2007 Jul;164(7):1121-2. No abstract available.

PMID:
17606668
4.

Venlafaxine-associated hypomania in unipolar depression.

Chand PK, Kalyani GS, Murthy P.

Can J Psychiatry. 2004 Jul;49(7):496. No abstract available.

PMID:
15362257
5.

Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.

Liberek C, Aubry JM, Baud P.

Therapie. 2006 Nov-Dec;61(6):531-3. No abstract available.

PMID:
17348610
6.

Toxic interaction of venlafaxine and isocarboxazide.

Klysner R, Larsen JK, Sørensen P, Hyllested M, Pedersen BD.

Lancet. 1995 Nov 11;346(8985):1298-9. No abstract available.

PMID:
7475741
7.

Suspected complication of treatment with venlafaxine.

Wilson R, Jenkins P.

J Clin Psychopharmacol. 1997 Aug;17(4):323. No abstract available.

PMID:
9241015
8.
9.

Even low-dose treatment of venlafaxine may provoke recurrence of hypertension in an Asian patient?

Bahk WM, Pae CU, Chae JH, Jun TY, Kim KS.

Gen Hosp Psychiatry. 2001 Jul-Aug;23(4):232-4. No abstract available.

PMID:
11569474
10.

Mania associated with venlafaxine discontinuation.

Fava GA, Mangelli L.

Int J Neuropsychopharmacol. 2003 Mar;6(1):89-90. No abstract available.

PMID:
12899740
11.

Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.

Gitlin MJ.

J Clin Psychopharmacol. 1997 Feb;17(1):66-7. No abstract available.

PMID:
9004070
12.

Venlafaxine-induced mania.

Yuksel FV, Basterzi AD, Goka E.

Can J Psychiatry. 2004 Nov;49(11):786-7. No abstract available.

PMID:
15633861
13.

An organic psychosis due to a venlafaxine-propafenone interaction.

Pfeffer F, Grube M.

Int J Psychiatry Med. 2001;31(4):427-32.

PMID:
11949740
14.

Venlafaxine withdrawal symptoms.

Benazzi F.

Can J Psychiatry. 1996 Sep;41(7):487. No abstract available.

PMID:
8884044
15.

Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial.

Fann JR, Bombardier CH, Richards JS, Wilson CS, Heinemann AW, Warren AM, Brooks L, McCullumsmith CB, Temkin NR, Warms C, Tate DG; PRISMS Investigators.

JAMA Psychiatry. 2015 Mar;72(3):247-58. doi: 10.1001/jamapsychiatry.2014.2482.

PMID:
25607727
16.

Venlafaxine-induced delirium.

Howe C, Ravasia S.

Can J Psychiatry. 2003 Mar;48(2):129. No abstract available.

PMID:
12655917
17.

Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia.

Ravindran AV, Charbonneau Y, Zaharia MD, al-Zaid K, Wiens A, Anisman H.

J Psychiatry Neurosci. 1998 Nov;23(5):288-92.

18.

Venlafaxine-induced hair loss.

Pitchot W, Ansseau M.

Am J Psychiatry. 2001 Jul;158(7):1159-60. No abstract available.

PMID:
11431245
19.

Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.

Nissen C, Feige B, Nofzinger E, Riemann D, Berger M, Voderholzer U.

J Sleep Res. 2005 Jun;14(2):207-8. No abstract available.

20.

Venlafaxine withdrawal syndrome.

Macbeth R, Rajagopalan M.

Aust N Z J Med. 1998 Apr;28(2):218. No abstract available.

PMID:
9612536

Supplemental Content

Support Center